What is Kwality Pharmaceuticals Ltd. Quarterly Revenue?

Kwality Pharmaceuticals Ltd. Quarterly Revenue Kwality Pharma Jun-2026 Quarterly Revenue is Rs 163 Cr which is growth of 45.7% YoY.

What is Kwality Pharmaceuticals Ltd. Quarterly Net Profit?

Kwality Pharmaceuticals Ltd. Quarterly Net Profit Kwality Pharma Jun-2026 Quarterly Net Profit is Rs 26 Cr which is growth of 114.8% YoY.

What is Kwality Pharmaceuticals Ltd. Annual Revenue?

Kwality Pharmaceuticals Ltd. Annual Revenue Kwality Pharma Mar-2026 Annual Revenue is Rs 506 Cr which is growth of 36.0% YoY.

What is Kwality Pharmaceuticals Ltd. Annual Net Profit?

Kwality Pharmaceuticals Ltd. Annual Net Profit Kwality Pharma Mar-2026 Annual Net Profit is Rs 67 Cr which is growth of 68.8% YoY.

What is Kwality Pharmaceuticals Ltd. Total Shareholders Fund?

Kwality Pharmaceuticals Ltd. Total Shareholders Fund Kwality Pharma Mar-2026 Total Shareholders Fund is Rs 333 Cr which is growth of 25.4% YoY.

What is Kwality Pharmaceuticals Ltd. Total Assets?

Kwality Pharmaceuticals Ltd. Total Assets Kwality Pharma Mar-2026 Total Assets is Rs 596 Cr which is growth of 32.2% YoY.

What is Kwality Pharmaceuticals Ltd. Book Value Per Share?

Kwality Pharmaceuticals Ltd. Book Value Per Share Kwality Pharma Mar-2026 Book Value Per Share is 321 Rs which is growth of 25.5% YoY.

What is Kwality Pharmaceuticals Ltd. ROE?

Kwality Pharmaceuticals Ltd. ROE Kwality Pharma Mar-2026 ROE is 20% which is growth of 5.2% YoY.

What is Kwality Pharmaceuticals Ltd. Cash From Operating Activity?

Kwality Pharmaceuticals Ltd. Cash From Operating Activity Kwality Pharma Mar-2026 Cash From Operating Activity is Rs 17 Cr which is growth of -67.8% YoY.

What is Kwality Pharmaceuticals Ltd. Net Cash Flow?

Kwality Pharmaceuticals Ltd. Net Cash Flow Kwality Pharma Mar-2026 Net Cash Flow is Rs -11 Cr which is growth of -206.6% YoY.

Kwality Pharmaceuticals Ltd.

BSE: 539997

Strong Performer, Getting Expensive

Download real time

-0.40(-0.01%)

329.81% Gain from 52W Low

14,434

NSE+BSE Volume

BSE 12 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Kwality Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Kwality Pharma quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Kwality Pharma Jun-2026 Quarterly Revenue is Rs 163 Cr which is growth of 45.7% YoY.
POSITIVE
Quarterly Net Profit Kwality Pharma Jun-2026 Quarterly Net Profit is Rs 26 Cr which is growth of 114.8% YoY.

Kwality Pharmaceuticals Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	163	157.9	124	112.2	111.9	116.4	85.1	90.3	80.4	92.6	78.7	69.9	67.9
SR_Q Operating Rev.	162.4	156.8	123.4	111.3	111.5	115.7	84.4	90	80.1	92	78.1	69.7	67.5
OI_Q Other Income	0.6	1.1	0.5	0.9	0.4	0.8	0.7	0.2	0.3	0.6	0.6	0.2	0.4
OEXPNS_Q Operating Exp.	121.3	118.1	93.5	86	87.3	89.8	66.9	70.4	62.7	71.1	61.4	54.4	53.6
OEXPNS_Q Operating Exp.	121.3	118.1	93.5	86	87.3	89.8	66.9	70.4	62.7	71.1	61.4	54.4	53.6
OP_Q Operating Profit	41	38.7	30	25.4	24.2	25.9	17.5	19.7	17.4	20.9	16.7	15.3	13.8
OPMPCT_Q Operating Profit Margin %	25.27%	24.70%	24.26%	22.78%	21.69%	22.39%	20.74%	21.86%	21.68%	22.68%	21.39%	21.92%	20.47%
DEP_Q Depr.	5	5.3	4.8	5	4.8	5.1	4.6	4.6	4	5	4.8	4.9	4.8
INT_Q Interest	2.7	2.9	2.5	2.8	2.8	2.5	2.2	2.7	2.5	3.1	2.7	2.4	2.2
PBT_Q Profit Before Tax	34	31.7	22.4	18.5	17	19.1	11.4	12.6	11.1	6.2	9.8	8.2	7.2
TAX_Q Tax	8.4	6.4	6.4	4.3	5.1	4.6	2.9	4.1	2.8	1.8	2.1	2	1.8
NP_Q Net Profit	25.6	25.3	16	14.1	11.9	14.5	8.5	8.5	8.4	4.5	7.7	6.3	5.5
EPS_adj_Q EPS Adj. latest	24.7	24.4	15.4	13.6	11.5	14	8.2	8.2	8.1	4.3	7.4	6	5.3
NP_TTM Net profit TTM	81	67.4	56.6	49.1	43.5	39.9	29.9	29.1	26.8	23.9	12.1	11.6	14.4
EPS_TTM Basic EPS TTM	78.1	64.9	54.5	47.3	41.9	38.4	28.8	28	25.9	23	11.6	11.2	13.8
earnings_transcripts Earnings Transcripts
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes		Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Kwality Pharma competitor comparison and performance snapshot within industry

Kwality Pharma annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Kwality Pharma Mar-2026 Annual Revenue is Rs 506 Cr which is growth of 36.0% YoY.
POSITIVE
Annual Net Profit Kwality Pharma Mar-2026 Annual Net Profit is Rs 67 Cr which is growth of 68.8% YoY.

Kwality Pharmaceuticals Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	25.8%	14%	557	505.9	372.1	309	253.9	459.6	263.1	142.6	166.1	137.9	96.8	76.4
TotalOperatingRevenues_A Operating Rev. Ann.	26.1%	14%	553.9	503.1	370.2	307.2	251	456.1	261.5	138.7	165.2	136.8	95.3	75.9
OI_A Other Income Ann.	0%	12.6%	3.1	2.9	1.9	1.8	2.9	3.5	1.6	3.9	0.9	1.1	1.5	0.6
OEXPNS_A Operating Exp. Ann.	26.4%	10.6%	418.9	384.8	289.8	240.5	190.7	284.4	232.2	124.6	149.9	125.3	86.8	70.5
OEXPNS_A Operating Exp. Ann.	26.4%	10.6%	418.9	384.8	289.8	240.5	190.7	284.4	232.2	124.6	149.9	125.3	86.8	70.5
OP_A Operating Profit Ann.	25.2%	32.2%	135.1	118.2	80.4	66.6	60.3	171.7	29.3	14.1	15.2	11.5	8.5	5.4
OPMPCT_A OPM Ann. %	-0.5%	16%		23.37%	21.62%	21.56%	23.74%	37.36%	11.12%	9.90%	9.17%	8.33%	8.82%	7.08%
TotalExpenses_A Total Exp. Ann. ⌄	25.2%	11.5%		415.6	317.9	270.4	211.7	298	241.3	131.5	155.2	130.4	91	73.3
OtherExpenses_A Other Exp. Ann.	12.6%	7.3%	74.4	72.4	63.5	54.8	50.7	63.7	51	25.8	22.1	18.5	13	10
EmployeeBenefitExpenses_A Employee Exp. Ann.	21.8%	28%	56.6	54	43.8	32.5	29.9	20.1	15.7	11.7	8.4	5.5	4.2	2.6
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	24.2%	31.4%		121.1	82.4	68.5	63.2	175.2	30.9	18	16.2	12.6	10.1	6
EBIDTPCT_A EBITDA Ann. margin %	-1.3%	15.3%		23.93%	22.13%	22.16%	24.90%	38.12%	11.73%	12.65%	9.73%	9.13%	10.38%	7.80%
INT_A Interest Ann.	22.4%	33.4%	10.9	11	9.9	10.4	6	2.9	2.6	2.5	2.2	2.2	1.9	1.2
DEP_A Depr.	9.9%	25.3%	20	19.8	18.3	19.5	14.9	10.6	6.4	4.4	3.1	2.9	2.4	1.7
PBT_A PBT Ann.	51.4%	32.6%	106.4	89.5	54.2	31.5	25.8	161.7	21.8	11.1	10.9	7.6	5.8	3.1
TAX_A Tax Ann.	52.2%	28.2%	25.4	22.2	14.3	7.5	6.3	41.6	6.4	2.7	3.4	2.9	2.4	1.2
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	51.2%	34.3%		67.4	39.9	24	19.5	120.1	15.4	8.4	7.6	4.7	3.4	1.9
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	51.2%	34.3%	81	67.4	39.9	24	19.5	120.1	15.4	8.4	7.6	4.7	3.4	1.9
NETPCT_A NPM Ann. %	20%	17.8%		13.38%	10.77%	7.80%	7.75%	26.31%	5.89%	6.07%	4.56%	3.41%	3.60%	2.48%
EPS_adj_A EPS Adj. latest Ann.	51.1%	34.2%		64.9	38.4	23.1	18.8	115.7	14.9	8.1	7.3	4.5	3.3	1.8
result_notes Result Notes				Notes			Notes						Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

36%

2Y CAGR

28%

3Y CAGR

25.8%

5Y CAGR

14%

7Y CAGR

17.2%

10Y CAGR

20.8%

Total Revenue Annual growth is higher than historical averages.

Net Profit Ann.

1Y CHG

68.9%

2Y CAGR

67.6%

3Y CAGR

51.2%

5Y CAGR

34.3%

7Y CAGR

36.6%

10Y CAGR

42.9%

Net Profit Annual growth is higher than historical averages.

Operating Exp. Ann.

1Y CHG

32.8%

2Y CAGR

26.5%

3Y CAGR

26.4%

5Y CAGR

10.6%

7Y CAGR

14.4%

10Y CAGR

18.5%

Operating Expenses Annual Cr growth is higher than historical averages.

Kwality Pharma balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Kwality Pharma Mar-2026 Total Shareholders Fund is Rs 333 Cr which is growth of 25.4% YoY.
POSITIVE
Total Assets Kwality Pharma Mar-2026 Total Assets is Rs 596 Cr which is growth of 32.2% YoY.

Kwality Pharmaceuticals Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	18.2%	39.8%	333.4	265.8	225.9	202	182.6	62.5	47.1	38.7	31.1	26.4	22.6
EQCAP_A Equity Share Capital Ann.	0%	0%	10.4	10.4	10.4	10.4	10.4	10.4	10.4	10.4	10.4	5.2	5
TotalShareCapital_A Total Share Capital Ann.	0%	0%	10.4	10.4	10.4	10.4	10.4	10.4	10.4	10.4	10.4	5.2	5
ReservesAndSurplus_A Reserves Plus Surplus Ann.	19.1%	44.4%	322.2	254.7	214.8	190.9	171.4	51.3	35.9	27.5	19.9	20.5	16.8
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	19%	44%	323	255.5	215.6	191.7	172.2	52.1	36.7	28.3	20.7	21.3	17.6
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	8.8%	5.5%	36.8	15.4	19.8	28.6	30.5	28.1	20	7.7	4.9	4.1	3.2
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	-	-				0.4	0.3			0.1	0.2	0.4	0.5
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-	-7.6%	6.2				9.2	9.2	9.2
CL_A Total Current Liabilities Ann. ⌄	21.4%	23.6%	225.5	169.5	151.9	125.9	129.6	78.2	67.6	60.7	61.7	41.5	26.5
TradePayables_A Trade Payables Ann.	42.4%	31.2%	101.7	55.8	44.3	35.2	34.5	26.2	23	17.1	21.9	12.7	9.7
OtherCurrentLiabilities_A Other Current Liabilities Ann.	1.7%	-5.5%	22.4	16.2	28.9	21.3	31.1	29.7	20.4	21.6	15.9	11.4	5.9
ShortTermProvisions_A ST Provisions Ann.	-60.5%	-41.4%	0.4	0.2	0.1	6.5	41	5.8	3	3.3	2.6	2.3	1.3
TL_A Total Capital Plus Liabilities Ann.	18.7%	28.7%	595.7	450.7	397.6	356.6	342.7	168.8	134.7	107	97.7	72	52.3
FixedAssets_A Fixed Assets Ann. ⌄	8.6%	24%	171.4	144.5	138.2	133.9	102.9	58.4	41.6	28	19.3	15.8	11.4
TangibleAssets_A Tangible Assets Ann.	7.5%	20.5%	148.5	142.8	138.2	119.6	90.8	58.4	41.6	28	19.3	15.8	11.4
IntangibleAssets_A Intangible Assets Ann.	-	-	5.9	1.7
CapitalWorkInProgress_A Capital Work In Progress Ann.	5.9%	-	17			14.3	12.2
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	8.2%	24.6%	188.9	165.8	154.2	149.1	115.4	62.9	46.2	32.8	23.6	19.7	14.4
NonCurrentInvestments_A Non Current Investments Ann.	0%	-3.5%	3.6	3.6	3.6	3.6	4.3	4.3	4.2	4.6	4.1	3.7	2.8
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-	2.5	1.6	0			0	0.2
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-					8.1	0.2	0.1	0.1	0.1	0.1	0.1
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-0.3%	-	11.5	16.2	12.4	11.6				0	0.1	0.1	0.1
CA_A Total Current Assets Ann. ⌄	25.2%	30.9%	406.8	284.9	243.4	207.5	227.3	105.9	88.5	74.2	74.1	52.3	37.9
CurrentInvestments_A Current Investments Ann.	-	-						4.4	3.3	3.8	4.4	2.9	1.9
TradeReceivables_A Trade Receivables Ann.	56.5%	49.4%	281.2	155.9	116	73.3	70.7	37.8	30.4	38.8	37.2	22.7	19.8
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-16.9%	-7.3%	3.5	14.3	5	6.1	10.9	5.1	1.2	0.3	1	2.4	1
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	-	-			16.4	10.4	92.4	41.2	31.3	20.1	16.5	10.5	6.5
OtherCurrentAssets_A Other Current Assets Ann.	11.6%	-	43.8	31.3	27.6	31.5			0	0	0	0	0
TA_A Total Assets Ann.	18.7%	28.7%	595.7	450.7	397.6	356.6	342.7	168.8	134.7	107	97.7	72	52.3
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	319.8%	128%	37	37	0.4	0.5	0.1	0.6	1.3	5.3	2.8	2.3
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	0%	5.7	5.7	5.7	5.7	5.7	5.7	5.7	5.7	5.7	0.5	0.5
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	0%	-3.5%	3.6	3.6	3.6	3.6	4.3	4.3	4.2	4.6	4.1	3.7	2.8
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-						4.4	3.3	3.8	4.4	2.9	1.9

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

32.2%

2Y CAGR

22.4%

3Y CAGR

18.7%

5Y CAGR

28.7%

7Y CAGR

27.8%

10Y CAGR

27.5%

Total Assets Annual growth is higher than historical averages.

Total Current Liabilities Ann.

1Y CHG

33%

2Y CAGR

21.8%

3Y CAGR

21.4%

5Y CAGR

23.6%

7Y CAGR

20.6%

10Y CAGR

23.9%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

25.4%

2Y CAGR

21.5%

3Y CAGR

18.2%

5Y CAGR

39.8%

7Y CAGR

36%

10Y CAGR

30.9%

Total ShareHolders Funds Annual growth is stable compared to historical averages.

Kwality Pharma ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Kwality Pharma Mar-2026 Book Value Per Share is 321 Rs which is growth of 25.5% YoY.
POSITIVE
ROE Kwality Pharma Mar-2026 ROE is 20% which is growth of 5.2% YoY.

Kwality Pharmaceuticals Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	18.2%	40%	320.5	255.4	217	193.9	175.2	59.5	44.6	36.5	29.2	49.4	43.5
ROA_A RoA Ann. %	27.5%	4.4%	11.30%	8.85%	6.03%	5.45%	35.03%	9.13%	6.26%	7.05%	4.78%	4.77%	3.60%
ROE_A ROE Ann. %	27.9%	-4.1%	20.25%	15.05%	10.65%	9.67%	66.04%	24.97%	18.21%	19.93%	15.42%	13.41%	8.66%
ROCE_A ROCE Ann. %	9.3%	0.3%	27.36%	22.79%	19.92%	20.94%	77.25%	26.93%	20.33%	28.29%	27.04%	25.18%	16.60%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	-1.5%	15.3%	24.07%	22.24%	22.28%	25.19%	38.41%	11.79%	13.00%	9.78%	9.20%	10.54%	7.85%
PBITMargin_A EBIT Ann. Margin %	1.5%	16.6%	20.13%	17.31%	15.93%	19.24%	36.08%	9.33%	9.83%	7.93%	7.11%	8.06%	5.62%
PBTMargin_A PBT Ann. Margin %	20.1%	16.4%	17.78%	14.64%	10.24%	10.26%	35.44%	8.33%	8.03%	6.59%	5.51%	6.09%	4.05%
NETPCT_A NPM Ann. %	20%	17.8%	13.38%	10.77%	7.80%	7.75%	26.31%	5.89%	6.07%	4.56%	3.41%	3.60%	2.48%
ASETTO_A Asset Turnover Ann. %	12.6%	-10.1%	1	0.9	0.8	0.7	1.8	1.7	1.2	1.6	1.6	1.5	1.7
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	1.9%	5.2%	1.8	1.7	1.6	1.7	1.8	1.4	1.3	1.2	1.2	1.3	1.4
QuickRatio_A Quick Ratio Ann.	14.5%	6.4%	1.5	1.2	1.1	1	1.3	1.1	1	1	1	0.9	1.1
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-						-	-	-	-	-	-
EarningRetention_A Earning Retention Ann. %	-	-										90.95%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-										94.65%
CashEarningRetention_A Cash Earning Retention Ann. %	-	-										94.65%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	54.3%	76%	1,482.4	999.9	517.9	403.3	634.2	87.7	56.8	63.9	67	65.7
EVPerNetSales_A EV Per Net Sales Ann.	23.3%	58.5%	3	2.7	1.7	1.6	1.4	0.3	0.4	0.4	0.5	0.7	-
PBV_A Price To Book Value Adjusted	-15.5%	-28.6%	11.09	15.22	16.42	18.37	20.34	59.9	79.84	97.62	121.93	72.08	81.97
EVPerEBITDA_A EV Per EBITDA Ann.	24%	34.2%	12.2	12.1	7.6	6.4	3.6	2.8	3.2	4	5.3	6.5	-
MarketCapPerSales_A Market Cap Per Sales Ann.	27.6%	68.3%	2.7	2.4	1.4	1.3	1.3	0.2	0.2	0.2	0.3	0.5	-
RetentionRatios_A Retention Ratio Ann. %	-	-										90.94%
EYield_A Earnings Yield Ann.	0%	-19.7%	0.1	0	0.1	0.1	0.2	0.3	0.3	0.2	0.1	0.1
DEBT_CE_A Total Debt to Total Equity Ann.	-7.2%	-7.8%	0.4	0.4	0.4	0.5	0.2	0.6	0.7	0.7	0.8	0.7	0.6

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

34.6%

2Y CAGR

37.9%

3Y CAGR

27.9%

5Y CAGR

-4.1%

7Y CAGR

0.2%

10Y CAGR

8.9%

ROE Annual % is growing faster than historical averages.

RoA Ann. %

1Y CHG

27.7%

2Y CAGR

36.9%

3Y CAGR

27.5%

5Y CAGR

4.4%

7Y CAGR

10Y CAGR

12.1%

RoA Annual % is growing faster than historical averages.

Current Ratio Ann.

1Y CHG

5.9%

2Y CAGR

6.1%

3Y CAGR

1.9%

5Y CAGR

5.2%

7Y CAGR

10Y CAGR

2.5%

Current Ratio Annual growth is higher than historical averages.

Kwality Pharma cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Kwality Pharma Mar-2026 Cash From Operating Activity is Rs 17 Cr which is growth of -67.8% YoY.
NEGATIVE
Net Cash Flow Kwality Pharma Mar-2026 Net Cash Flow is Rs -11 Cr which is growth of -206.6% YoY.

Kwality Pharmaceuticals Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	-26.1%	-8.4%	17	52.8	43.4	42.2	63.1	26.4	5.6	13	-0.1	4	-2.6
PBT_A PBT Ann.	51.4%	32.6%	89.5	54.2	31.5	25.8	161.7	21.8	11.1	10.9	7.6	5.8	3.1
INT_A Interest Ann.	22.4%	33.4%	11	9.9	10.4	6	2.9	2.6	2.5	2.2	2.2	1.9	1.2
TAX_A Tax Ann.	52.2%	28.2%	22.2	14.3	7.5	6.3	41.6	6.4	2.7	3.4	2.9	2.4	1.2
CFI_A Cash from Investing Act. Ann.	-	-	-34.9	-28.1	-26.4	-48.4	-63	-23.2	-17.1	-11.8	-6.2	-7.3	-2.4
CFA_A Cash from Financing Act. Ann.	91.3%	54.3%	7	-14.4	-17.4	1	5.7	0.8	12.4	-1.9	5	4.6	5.5
NCF_A Net Cash Flow Ann. ⌄	-	-	-10.9	10.2	-0.5	-5.3	5.7	4	0.9	-0.8	-1.3	1.4	0.5
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	17.8%	57.4%	11.6	1.4	1.8	7.1	5.1	1.2	0.3	1	2.4	1	0.5
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-27%	-32.8%	0.7	11.6	1.4	1.8	10.9	5.1	1.2	0.3	1	2.4	1

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

-67.8%

2Y CAGR

-37.4%

3Y CAGR

-26.1%

5Y CAGR

-8.4%

7Y CAGR

3.9%

Cash from Operating Activity Annual is falling faster than historical averages.

Cash from Financing Act. Ann.

3Y CAGR

91.3%

5Y CAGR

54.3%

10Y CAGR

2.4%

Cash from Financing Annual Activity growth is stable compared to historical averages.

Kwality Pharma investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

329.81% Gain from 52W Low

Kwality Pharma quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents